Literature DB >> 15866362

Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.

Peruvamba N Jayakumar1, Ganesan Venkatasubramanian, Bangalore N Gangadhar, Nimmagadda Janakiramaiah, Matcheri S Keshavan.   

Abstract

This study examined gray matter (GM) volume abnormalities in first-episode, antipsychotic-naïve Indian schizophrenia patients. Magnetic resonance images of 18 schizophrenia patients and 18 matched healthy comparison subjects were analyzed by optimized voxel-based morphometry. Schizophrenia patients had significantly smaller global GM and greater global CSF volumes and smaller regional GM volume in superior frontal, inferior frontal, cingulate, post-central, superior temporal and parahippocampal gyri, inferior parietal lobule, insula, caudate nuclei, thalamus and cerebellum. Findings suggest limbic, heteromodal cortical, striatal, thalamic and cerebellar abnormalities in schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 15866362     DOI: 10.1016/j.pnpbp.2005.01.020

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  32 in total

1.  Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry.

Authors:  Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-28       Impact factor: 5.270

Review 2.  The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.

Authors:  Lynn E DeLisi
Journal:  Schizophr Bull       Date:  2008-02-08       Impact factor: 9.306

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 4.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

5.  Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.

Authors:  Tianhao Zhang; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Davatzikos
Journal:  Schizophr Bull       Date:  2014-09-26       Impact factor: 9.306

6.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis.

Authors:  Ian Ellison-Wright; David C Glahn; Angela R Laird; Sarah M Thelen; Ed Bullmore
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

7.  Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia.

Authors:  Ganesan Venkatasubramanian
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

8.  Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.

Authors:  Kevin Yu; Charlton Cheung; Meikei Leung; Qi Li; Siew Chua; Gráinne McAlonan
Journal:  Front Hum Neurosci       Date:  2010-10-26       Impact factor: 3.169

9.  DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia.

Authors:  Philip R Szeszko; Colin A Hodgkinson; Delbert G Robinson; Pamela Derosse; Robert M Bilder; Todd Lencz; Katherine E Burdick; Barbara Napolitano; Julia D Betensky; John M Kane; David Goldman; Anil K Malhotra
Journal:  Biol Psychol       Date:  2007-11-01       Impact factor: 3.251

10.  Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression.

Authors:  Raymond C K Chan; Xin Di; Grainne M McAlonan; Qi-yong Gong
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.